Pandey, A.; Ajgaonkar, S.; Jadhav, N.; Saha, P.; Gurav, P.; Panda, S.; Mehta, D.; Nair, S.
Current Insights into miRNA and lncRNA Dysregulation in Diabetes: Signal Transduction, Clinical Trials and Biomarker Discovery. Pharmaceuticals 2022, 15, 1269.
https://doi.org/10.3390/ph15101269
AMA Style
Pandey A, Ajgaonkar S, Jadhav N, Saha P, Gurav P, Panda S, Mehta D, Nair S.
Current Insights into miRNA and lncRNA Dysregulation in Diabetes: Signal Transduction, Clinical Trials and Biomarker Discovery. Pharmaceuticals. 2022; 15(10):1269.
https://doi.org/10.3390/ph15101269
Chicago/Turabian Style
Pandey, Amitkumar, Saiprasad Ajgaonkar, Nikita Jadhav, Praful Saha, Pranay Gurav, Sangita Panda, Dilip Mehta, and Sujit Nair.
2022. "Current Insights into miRNA and lncRNA Dysregulation in Diabetes: Signal Transduction, Clinical Trials and Biomarker Discovery" Pharmaceuticals 15, no. 10: 1269.
https://doi.org/10.3390/ph15101269
APA Style
Pandey, A., Ajgaonkar, S., Jadhav, N., Saha, P., Gurav, P., Panda, S., Mehta, D., & Nair, S.
(2022). Current Insights into miRNA and lncRNA Dysregulation in Diabetes: Signal Transduction, Clinical Trials and Biomarker Discovery. Pharmaceuticals, 15(10), 1269.
https://doi.org/10.3390/ph15101269